Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB vs TEGASEROD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB vs TEGASEROD: Safety Overview

Metric TECLISTAMAB TEGASEROD
Total FAERS Reports 1,221 102
Deaths Reported 269 2
Death Rate 22.0% 2.0%
Hospitalizations 540 13
Average Patient Age 66.5 yrs 62.0 yrs
% Female Patients 45.7% 81.1%
FDA Approval Date N/A Jul 24, 2002
Manufacturer Janssen Biotech, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Discontinued